| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.3M | — | +29.5% |
| Cost of Revenue | $175K | — | -18.6% |
| Gross Profit | $1.1M | — | +43.2% |
| R&D Expense | $2K | — | +0.0% |
| SG&A Expense | $861K | — | +15.2% |
| Pre-tax Income | $195K | — | +496.6% |
| Net Income | $195K | — | +496.6% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.3M | +13.0% | +85.4% |
| Accounts Receivable | $149K | -28.3% | -50.4% |
| Inventory | $101K | -2.1% | +184.4% |
| Current Assets | $1.6M | +7.1% | +49.4% |
| Total Assets | $1.7M | +6.6% | +45.0% |
| Total Liabilities | $1.9M | -4.6% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $148K | — | +189.6% |
| Investing Cash Flow | -$2K | — | — |
| +30.8% |
| Stockholders' Equity | -$162K | +54.6% | +35.7% |